本文へスキップ

相互作用

Elacestrant + Enzalutamide

重症度: 重大

Elacestrant and Enzalutamide: major interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Strong CYP3A inducers reduce elacestrant exposure and may compromise its efficacy in breast cancer. Enzalutamide is expected to have this effect.

この相互作用をわかりやすく説明すると

Elacestrant and Enzalutamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Elacestrant belongs to Oncology; Enzalutamide belongs to Endocrine.

エビデンスレベル: Moderate

なぜ起こるのか

CYP3A4 induction by enzalutamide accelerates elacestrant metabolism.

対処法

Avoid coadministration; labeling recommends avoiding strong and moderate CYP3A inducers. Choose an alternative therapy where possible.

薬剤師に尋ねること

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、ElacestrantとEnzalutamideの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を14日間無料でお試し。カード登録不要。

よくある質問

Can I take Elacestrant with Enzalutamide?

MediHelp rates the interaction as major. Elacestrant and Enzalutamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Strong CYP3A inducers reduce elacestrant exposure and may compromise its efficacy in breast cancer. Enzalutamide is expected to have this effect.

How serious is the interaction between Elacestrant and Enzalutamide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid coadministration; labeling recommends avoiding strong and moderate CYP3A inducers. Choose an alternative therapy where possible.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン